Clinical Development and Labeling of Anti-Infective Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 12, 2001
May 6, 2020
67f316ae-b6a3-4be9-9f04-f8ca70727735
Related Documents
Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
Preparation of Investigational New Drug Products (Human and Animal): Guidance for Industry
Guidance DocumentNovember 1, 1992Center for Drug Evaluation and Research
Format and Content of the Nonclinical Pharmacology/Toxicology Section of an Application*: Guidance for Industry
Guidance DocumentFebruary 1, 1987Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.